Non-Contrast Abbreviated Magnetic Resonance Imaging: A Cost-Effective Rookie in Hepatocellular Carcinoma Surveillance for Cirrhotic Patients

참고문헌 (10)

1. Tzartzeva K, "Surveillance imaging and alpha fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis : a meta-analysis", Gastroenterology, 154, pp.1706~1718 (2018)
2. Singal A, "Meta-analysis : surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis", Aliment Pharmacol Ther, 30, pp.37~47 (2009)
3. Kim SY, "MRI with liver-specific contrast for surveillance of patients with cirrhosis at high risk of hepatocellular carcinoma", JAMA Oncol, 3, pp.456~463 (2017)
4. Vietti Violi N, "Gadoxetate-enhanced abbreviated MRI is highly accurate for hepatocellular carcinoma screening", Eur Radiol, 30, pp.6003~6013 (2020)
5. Park HJ, "Non-enhanced magnetic resonance imaging as a surveillance tool for hepatocellular carcinoma : comparison with ultrasound", J Hepatol, 72, pp.718~724 (2020)
6. Chan MV, "HCC screening : assessment of an abbreviated non-contrast MRI protocol", Eur Radiol Exp, 3, pp.49~ (2019)
7. Whang S, "Comparison of diagnostic performance of non-contrast MRI and abbreviated MRI using gadoxetic acid in initially diagnosed hepatocellular carcinoma patients : a simulation study of surveillance for hepatocellular carcinomas", Eur Radiol, 30, pp.4150~4163 (2020)
8. Kim HL, "Magnetic resonance imaging is cost-effective for hepatocellular carcinoma surveillance in high-risk patients with cirrhosis", Hepatology, 69, pp.1599~1613 (2019)
9. Nahon P, "Early hepatocellular carcinoma detection using magnetic resonance imaging is cost-effective in high-risk patients with cirrhosis", JHEP Rep, 4, pp.100390~ (2021)
10. Decharatanachart P, "Cost-utility analysis of non-contrast abbreviated magnetic resonance imaging for hepatocellular carcinoma surveillance in cirrhosis", Gut Liver, 18, pp.135~146 (2024)

관련 논문AI추천